Transparency data

Voluntary scheme aggregate net sales and payment information: November 2020

Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.

From:
Department of Health and Social Care
Published
8 December 2020
Last updated
1 February 2021 — See all updates

Documents

Aggregate net sales and payment information: 16 November 2020 (corrected)

HTML

Details

This document sets out the NHS’s quarterly aggregate net sales and payment information on pharmaceuticals for November 2020.

The 2019 voluntary scheme for branded medicines pricing and access is an agreement between DHSC and the Association of the British Pharmaceutical Industry (ABPI) on getting the best value and most effective medicines into use more quickly.

Updates to this page

Published 8 December 2020
Last updated 1 February 2021 + show all updates

  1. Amended to reflect the change of the 2021 payment percentage under the voluntary scheme for branded medicines from 6.6% to 5.1%.

  2. First published.

Sign up for emails or print this page

Related content